Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
iBio, Inc. (IBIO) had Non-Operating Income/Expense of $0.02M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.86M |
|
-- |
|
-- |
|
$4.88M |
|
$-4.88M |
|
|
Non-Operating Income/Expense |
$0.02M |
$-4.86M |
|
$-4.86M |
|
$-4.86M |
|
$-4.86M |
|
$-4.86M |
|
$-4.86M |
|
$-4.88M |
|
$-4.60M |
|
9.86M |
|
9.86M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$6.06M |
|
$3.28M |
|
$13.04M |
|
$19.10M |
|
$5.40M |
|
-- |
|
$2.33M |
|
$7.72M |
|
$11.38M |
|
$5.28M |
|
$11.38M |
|
10.07M |
|
| Cash Flow Statement Financials | |
$-10.69M |
|
$0.70M |
|
$0.75M |
|
$14.43M |
|
$5.18M |
|
$-9.24M |
|
$1.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.12 |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-42.71% |
|
-92.10% |
|
-25.45% |
|
-42.71% |
|
$1.13 |
|
$-1.09 |
|
$-1.08 |
|